Tenaya Therapeutics Net Debt Growth & History (TNYA)

Tenaya Therapeutics's net debt was −$89.7M for fiscal 2025.

View full Tenaya Therapeutics company overview

Tenaya Therapeutics annual net debt history

Tenaya Therapeutics annual net debt

Fiscal yearPeriod endedNet debtChangeGrowth
20252025-12-31−$89.7M−$99.0M
20242024-12-31$9.3M$42.5M
20232023-12-31−$33.3M$46.9M
20222022-12-31−$80.2M−$57.7M
20212021-12-31−$22.4M

Tenaya Therapeutics net debt trends

Between the periods ended 2021-12-31 and 2025-12-31, Tenaya Therapeutics's net debt decreased from −$22.4M to −$89.7M, a change of −$67.3M. The latest reported quarter, Q2 2026, shows −$74.1M.

About the metric

What net debt means

Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.

Calculation and source

How net debt is calculated

TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Tenaya Therapeutics source filings ↗

Community posts

It’s quiet here.

No posts about TNYA yet. Start the conversation.

Write the first post